News
A new risk model uses objective clinical data to predict cure or relapse in Hodgkin lymphoma, with future plans to guide treatment and survivorship care.
Hosted on MSN10d
Modella AI and AstraZeneca link for cancer clinical developmentThe agreement will enable the use of Modella AI’s latest models, with rich feature extraction from different types of data, ...
LAB was established to standardize the transfer of data between clinical laboratories and sponsor companies. The CDISC LAB model is widely used in pharmaceutical and biotechnology companies today.
A new AI algorithm is nearly twice as accurate as physicians at forecasting a sudden cardiac arrest in people with ...
Researchers develop an AI model that uses ECG data to predict the risk for adverse vascular events in patients with migraine.
Over the past decade, artificial intelligence (AI) and automation have reshaped clinical research. From identifying drug ...
Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...
Lakshmi Priya Darshini Pulavarthi blends scientific expertise with data management to drive clinical trial success across oncology, hematology, and cardiovascular therapeutic areas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results